Sodium Hyaluronate, the sodium salt of hyaluronic acid, is a glycosaminoglycan renowned for its exceptional water-binding capacity. A single gram can hold up to six liters of water, making it a cornerstone of modern hydrating biomaterials. Its mechanism extends beyond superficial moisture; it integrates into the skin's extracellular matrix, providing structural support and facilitating nutrient transport.
At Beyond Biopharma, our focus is on sourcing and stabilizing high-purity, multi-molecular-weight Sodium Hyaluronate. This ensures a tiered delivery system where larger molecules form a protective, hydrating film on the skin's surface, while smaller, low-molecular-weight fractions penetrate the stratum corneum to deliver hydration and signal for collagen synthesis deep within the dermis. This dual-action approach addresses both immediate dryness and long-term skin health.
While celebrated in serums and creams, Sodium Hyaluronate's medical and therapeutic applications are vast and scientifically robust. In ophthalmology, it is a critical component of viscoelastic solutions used during cataract and other intraocular surgeries to protect delicate corneal endothelial cells and maintain chamber depth.
In orthopedics, intra-articular injections of highly purified, high-molecular-weight Sodium Hyaluronate serve as a viscosupplement for osteoarthritic joints. It restores the cushioning and lubricating properties of diminished synovial fluid, reducing pain and improving mobility. Beyond Biopharma supplies raw materials that meet the stringent specifications required for these sensitive medical device and pharmaceutical applications, emphasizing consistency, ultra-low endotoxin levels, and traceable sourcing.
The efficacy of Sodium Hyaluronate is intrinsically linked to its molecular weight. Formulators must select based on the desired target and outcome. High Molecular Weight (HMW, >1,000 kDa) HA acts as a superb film-former, creating a non-occlusive barrier that locks in moisture and protects against transepidermal water loss. It provides immediate, tangible smoothness and plumping.
Low Molecular Weight (LMW, <50 kDa) and oligo-HA fragments possess enhanced bioavailability. They can modulate cellular processes, including promoting fibroblast proliferation and downregulating inflammatory markers. The industry trend, which we champion, is towards synergistic blends. By combining multiple molecular weights, a single formulation can deliver immediate sensory benefits, lasting hydration, and deeper, bioactive signaling for comprehensive skin rejuvenation.
| Molecular Weight Range | Primary Function | Key Applications | Typical Use Concentration | Beyond Biopharma Grade |
|---|---|---|---|---|
| High (>1,500 kDa) | Film-forming, Surface Hydration, Barrier Protection | Leave-on creams, lotions, medical device coatings | 0.1% - 0.5% | UltraHA-H |
| Medium (500 - 1,500 kDa) | Balanced Hydration, Texture Enhancement | Serums, gels, moisturizers, sprayable formulations | 0.2% - 1.0% | UltraHA-M |
| Low (50 - 500 kDa) | Epidermal Penetration, Hydration Reserve | Anti-aging serums, ampoules, under-eye products | 0.5% - 2.0% | UltraHA-L |
| Oligo (<50 kDa) | Bioactive Signaling, Deep Dermal Support | High-performance treatments, professional skincare | 0.05% - 0.5% | UltraHA-O |
| Cross-linked / Stabilized | Prolonged Release, Extended Hydration | Night masks, sustained-release patches, fillers (medical) | Varies by technology | UltraHA-X |
Sodium Hyaluronate functions as a humectant, binding and retaining water molecules within the skin's dermal and epidermal layers. Its unique polymeric structure creates a viscoelastic matrix that supports the skin's natural moisture barrier, leading to improved elasticity and a reduction in the appearance of fine lines.
Lower molecular weight Sodium Hyaluronate fragments (typically below 50 kDa) demonstrate enhanced skin penetration, reaching deeper dermal layers to stimulate collagen production. Higher molecular weight forms (over 1,000 kDa) remain primarily on the surface, providing immediate occlusion and forming a protective, hydrating film. A multi-weight formulation offers comprehensive benefits.
Intra-articular injections of high-purity, high-molecular-weight Sodium Hyaluronate are a well-established viscosupplementation therapy. Clinical studies show it improves synovial fluid viscosity and elasticity, reduces pain, and enhances mobility in patients with osteoarthritis by providing cushioning and lubrication to the joint.
Pharmaceutical-grade material is characterized by extremely low endotoxin levels (<0.05 EU/mg), high molecular weight consistency (narrow polydispersity index), absence of protein and nucleic acid contaminants, and a defined moisture content. These parameters are critical for safety, especially in injectable and ophthalmic applications.
Stabilized or cross-linked Sodium Hyaluronate offers significantly increased residence time on the skin. This technology slows degradation, allowing for prolonged hydration and sustained release of benefits over many hours, compared to standard forms which may be absorbed or broken down more quickly.
+86 18657345785
NO.137 Haining Road, Hongkou District, Shanghai China
English EN
中国 CN
